Skip to main content

Bioanalysis Zone is part of Taylor & Francis Group.

  • Taylor & Francis
  • About us
  • Our journals
  • Our Digital Hubs

Taylor & Francis Group is a trading division of Informa that operates through various Informa legal entities including, but not limited to, Informa UK Limited, with the registered address at 5 Howick Place, London, SW1P 1WG, UK.

Taylor & Francis
logo
 
  • Home
  • Awards
  • Events
  • Features
    • An author's perspective
    • Ask the Experts
    • Conference reports
    • eBooks
    • Expert opinion
    • In the Zone
    • Journal articles
    • Journal content
    • Spotlights
    • Tech Digest

    Follow us on social media

  • Glossary
  • Topics
    • Applications
      • Advanced therapies
      • Biomarkers
      • Clinical
      • Diagnostics
      • Drug development
      • Forensics
      • Patient-centric sampling
      • Sports drug testing
      • Toxicology
      • Vaccines
    • Industry updates & regulations
      • Biopharmaceuticals
      • Collaborations & mergers
      • Data processing and interpretation
      • Regulated bioanalysis
    • Molecules
      • Antibodies | ADCs
      • Biosimilars
      • Large molecules
      • Metabolites
      • Oligonucleotides
      • Small molecules
    • Techniques
      • Automation
      • Chromatography
      • Imaging
      • LBA
      • Microsampling
      • MS (LC–MS/MS, HRMS, IMS)
      • Sample preparation

    Follow us on social media

  • Multimedia
    • Coffee chats
    • Infographics
    • Interviews
    • Panel discussions
    • Podcasts
    • Videos
    • Webinars

    Follow us on social media

  • News
  • Partners
  • Register
Now available on-demand! Cracking the code: learnings from oligonucleotide method development WATCH NOW

Outsourcing in the bioanalytical field: an interview with Song Li

21 May 2018
Data processing and interpretation Interviews

In this interview, Song Li from Frontage Laboratories (PA, USA) discusses the key challenges of outsourcing in the bioanalytical field, as well as his thoughts and perspectives on what the future holds for the relationship between CROs and pharma.

Related tags

CRO Frontage outsourcing
Previous article Next article

Related articles

1 SEP 2017 GENERAL INTEREST
Business of bioanalysis: Managing the pipeline of bioanalytical talent and staff
7 MAR 2018 INTERVIEWS
An interview with Shane Needham on data sharing, ALICE technology and co-founding a CRO
26 MAY 2025 INTERVIEWS
The capabilities of KCAS Bio: PK, biomarkers and immunogenicity testing all under one roof
1 SEP 2017 GENERAL INTEREST
Business of bioanalysis: Bioanalysis Zone panel discussion
4 SEP 2017 INTERVIEWS
Afshin Safavi, shares his perspective on the past, present and future of bioanalytical outsourcing (BioAgilytx)
7 JAN 2026 AUTOMATION
KCAS Bio strengthens bioanalytical support for sponsor programs with the NULISA™–ARGO™ HT
  • About
  • Advertising & Sponsorship
  • Learn
    • Awareness
    • Education zone
    • Professional development
  • Contact Us
  • Permissions
  • Products
  • Zone Leaders
  • Whitelist Emails
  • Accessibility

Contact

Contact Us

Office info

Bioanalysis Zone is powered by Taylor & Francis Group

Bioanalysis Zone, 2-4 Park Square, Milton Park, Abingdon, Oxfordshire, OX14 4RN, United Kingdom
  • Taylor & Francis Group
  • Cookie Policy
  • Privacy Policy
  • Terms & Conditions
  • © 2026 Bioanalysis Zone